Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...

The analyst's note also provides a comprehensive review of the key points from KLA's recent earnings report and conference call. It includes details on the company's impressive financial results and ...